PrismaSol Solution
FDA Approves Procysbi for Rare Genetic Condition »
"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...
Read the FDA Approves Procysbi for Rare Genetic Condition article »
PrismaSol Solution
PrismaSol Solution (sterile hemofiltration hemodiafiltration solution)
PrismaSol BGK 4/2.5
PrismaSol BGK 4/0/1.2
PrismaSol BK 0/0/1.2
PrismaSol BGK 2/3.5
PrismaSol BGK 2/0
PrismaSol BK 0/3.5
PrismaSol BGK 0/2.5
PrismaSol B22GK 4/0
PrismaSol B22GK 4/2.5
PrismaSol B22GK 2/0
Sterile Hemofitration and Hemodiafiltration Solution
DRUG DESCRIPTION
PrismaSol solution (sterile hemofiltration hemodiafiltration solution) is a clear, sterile solution free of bacterial endotoxins. This solution is used in Continuous Renal Replacement Therapies (CRRT) as a replacement solution in hemofiltration and hemodiafiltration.
It contains no bacteriostatic or antimicrobial agents.
PrismaSol solution (sterile hemofiltration hemodiafiltration solution) is packaged in a two-compartment bag. The small compartment A contains electrolytes and the large compartment B contains buffer. The final reconstituted solution (5000 mL) is obtained after breaking the red frangible pin between compartments A and B and mixing both solutions. The compositions of the solution before and after reconstitution are described in the following tables.
BEFORE RECONSTITUTION
1000 mL of electrolyte solution (small compartment A) contains
(g)
| PrismaSol BGK 4/2.5 |
PrismaSol BGK 2/3.5 |
PrismaSol BGK 0/2.5 |
PrismaSol B22GK 4/2.5 |
|
| Calcium chloride•2H2O | 3.68 | 5.15 | 3.68 | 3.68 |
| Magnesium chloride•6H2O | 3.05 | 2.03 | 3.05 | 3.05 |
| Dextrose anhydrous | 20.0 | 20.0 | 20.0 | 20.0 |
| (as dextrose monohydrate) | 22.0 | 22.0 | 22.0 | 22.0 |
| Lactic acid | 5.40 | 5.40 | 5.40 | 5.40 |
1000mL of buffer solution (large compartment B) contains
(g)
| PrismaSol BGK 4/2.5 |
PrismaSol BGK 2/3.5 |
PrismaSol BGK 0/2.5 |
PrismaSol B22GK 4/2.5 |
|
| Sodium chloride | 6.46 | 6.46 | 6.46 | 7 .07 |
| Sodium bicarbonate | 3.09 | 3.09 | 3.09 | 2.21 |
| Potassium chloride | 0.314 | 0.157 | 0 | 0.314 |
1000 mL of electrolyte solution (small compartment A) contains
(g)
| PrismaSol BGK4/0/1.2 |
PrismaSol BGK 2/0 |
PrismaSol B22GK4/0 |
PrismaSol B22GK 2/0 |
PrismaSol BK 0/0/1.2 |
PrismaSol BK 0/3.5 |
|
| Calcium chloride•2H2O | 0 | 0 | 0 | 0 | 0 | 5.15 |
| Magnesium chloride•6H2O | 2.44 | 2.03 | 3.05 | 3.05 | 2.44 | 2.03 |
| Dextrose anhydrous | 20.0 | 20.0 | 20.0 | 20.0 | 0 | 0 |
| (as dextrose monohydrate) | 22.0 | 22.0 | 22.0 | 22.0 | 0 | 0 |
| Lactic acid | 5.40 | 5.40 | 5.40 | 5.40 | 5.40 | 5.40 |
1000 mL of buffer solution (large compartment B) contains
(g)
| PrismaSol BGK4/0/1.2 |
PrismaSol BGK 2/0 |
PrismaSol B22GK 4/0 |
PrismaSol B22GK 2/0 |
PrismaSol BK 0/0/1.2 |
PrismaSol BK 0/3.5 |
|
| Sodium chloride | 6.46 | 6.46 | 7.07 | 7.07 | 6.46 | 6.46 |
| Sodium bicarbonate | 3.09 | 3.09 | 2.21 | 2.21 | 3.09 | 3.09 |
| Potassium chloride | 0.314 | 0.157 | 0.314 | 0.157 | 0 | 0 |
AFTER RECONSTITUTION of compartments A and B
1000 mL of the reconstituted solution contains
| in mEq/L except where noted | PrismaSol BGK 4/2.5 |
PrismaSol BGK 2/3.5 |
PrismaSol BGK 0/2.5 |
PrismaSol B22GK 4/2.5 |
| CalciumCa2+ | 2.5 | 3.5 | 2.5 | 2.5 |
| Bicarbonate HCO3 | 32 | 32 | 32 | 22 |
| Potassium K+ | 4.0 | 2.0 | 0 | 4.0 |
| Magnesium Mg2+ | 1.5 | 1.0 | 1.5 | 1.5 |
| Sodium Na+ | 140 | 140 | 140 | 1140 |
| Chloride Cl | 113 | 111.5 | 109 | 123 |
| Lactate | 3.0 | 3.0 | 3.0 | 3.0 |
| Dextrose | 100 mg/dL | 100 mg/dL | 100 mg/dL | 100 mg/dL |
| Theoretical | 300 mOsm/L | 296 mOsm/L | 292 mOsm/L | 300 mOsm/L |
| in mEq/L except where noted | PrismaSol BGK 4/0/1.2 |
PrismaSol BGK 2/0 |
PrismaSol B22GK 4/0 |
PrismaSol B22GK 2/0 |
| Calcium Ca2+ | 0 | 0 | 0 | 0 |
| Bicarbonate HCO3 | 32 | 32 | 22 | 22 |
| Potassium K+ | 4.0 | 2.0 | 4.0 | 2.0 |
| Magnesium Mg2+ | 1.2 | 1.0 | 1.5 | 1.5 |
| Sodium Na+ | 140 | 140 | 140 | 140 |
| Chloride Cl | 110.2 | 108 | 120.5 | 118.5 |
| Lactate | 3.0 | 3.0 | 3.0 | 3.0 |
| Dextrose | 100 mg/dL | 100 mg/dL | 100 mg/dL | 100 mg/dL |
| Theoretical Osmolarity | 295 mOsm/L | 295 mOsm/L | 295 mOsm/L | 295 mOsm/L |
| In mEq/L except where noted | PrismaSol BK 0/0/1.2 |
PrismaSol BK 0/3.5 |
| Calcium Ca2+ | 0 | 3.5 |
| Bicarbonate HCO3 | 32 | 32 |
| Potassium K+ | 0 | 0 |
| Magnesium Mg2+ | 1.2 | 1.0 |
| Sodium Na+ | 140 | 140 |
| Chloride Cl | ,106.2 | 109.5 |
| Lactate | 3.0 | 3.0 |
| Dextrose | 0 | 0 |
| Theoretical Osmolarity | 282 mOsm/L | 287 mOsm/L |
Calcium chloride, USP, is chemically designated calcium chloride dihydrate
(CaCl2•2 H2O).
Magnesium chloride, USP, is chemically designated magnesium chloride hexahydrate
(MgCl2•6H2O).
Dextrose, USP, is chemically designated D-Glucose anhydrous (C6H12O6)
or D-Glucose monohydrate (C6H12O6•H2O).
Lactic acid, USP, is chemically designated CH3CH(OH)COOH.
Sodium chloride, USP, is chemically designated NaCl.
Potassium chloride, USP, is chemically designated KCl.
Sodium bicarbonate, USP, is chemically designated NaHCO3.
The pH of the final solution is in the range of 7.0 to 8.5.
Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g. di 2-ethylhexyl phthalate (DEHP), up to 3 parts per milion; however, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by in-vitro toxicity studies.
Last reviewed on RxList: 12/29/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional PrismaSol Solution Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
